Overcoming Resistance to Anti-CD20 Antibodies: A Comprehensive Guide

Resistance to Anti-CD20 Antibodies and Approaches for Their Reversal, edited by William Chi Shing Cho, presents a cutting-edge exploration of the challenges and opportunities in the study of anti-CD20 antibodies. These life-saving therapies have revolutionized the treatment of B cell malignancies, including non-Hodgkin’s lymphoma and chronic lymphocytic leukemia, over the past two decades.

The Challenge of Resistance

Despite their success, a significant number of patients fail to respond to initial therapy or relapse sooner. This pressing issue has sparked intense research into the mechanisms of resistance and potential strategies for reversal. The book delves into the latest research on next-generation anti-CD20 therapies, highlighting the progress made and the challenges that remain.

A Valuable Resource for Researchers and Clinicians

This book is an indispensable guide for researchers, students, and professionals in the biomedical and medical fields seeking to deepen their understanding of resistance to anti-CD20 antibodies and approaches for their reversal. The comprehensive coverage includes:

• Presentation of current research and critical analyses on anti-CD20 antibody treatment
• In-depth literature reviews on recent developments in cancer and non-cancer disease treatment
• Discussion of possible resistance mechanisms and their reversals
• Exploration of exciting therapeutic opportunities offered by anti-CD20 antibodies in combination with chemotherapy or other treatment modalities

Visual Aids and Summaries

The book features a range of diagrams to illustrate complex concepts and tables to summarize important information, making it easier for readers to grasp the subject matter.

Published by Elsevier Science, this valuable resource is available in English and can be identified by the following ISBN numbers: 9780443192005 and 9780443192012.

Stay up-to-date with the latest research and advancements in the field of anti-CD20 antibodies and unlock the full potential of these life-saving therapies.